Among more than 5,000 patients followed for a median of roughly 8 years, bilateral risk-reducing mastectomy (RRM) was ...

Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer ...

Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment ...

Detections of ctDNA at baseline in patients with HR-positive early breast cancer were associated with larger tumor size.

Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...

For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the ...

Imlunestrant, a next-generation SERD, improves progression-free survival in ER-positive advanced breast cancer patients ...

For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced ...

Two recent studies suggest that some early breast cancer patients may skip certain surgeries, potentially reducing treatment ...

Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent chest wall irradiation (CWI) after mastectomy, according to results from the ...

Two studies suggest that early breast cancer patients can safely avoid specific surgeries, including lymph node removal, and ...

Two recent studies have found that some early breast cancer patients may not need specific surgeries, offering potential ways ...